2CUREX.ST Gross Margin

The Gross Margin of 2cureX AB (2CUREX.ST) is -1152.26%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

2CUREX.ST Gross Margin - Historical Value

Date	Value
2024-12-31	-1152.26%
2023-12-31	-1052.26%
2022-12-31	-13660.00%
2021-12-31	-7368.09%

2CUREX.ST Gross Margin - Peers Comparison

Ticker	Name	Value
IGPH.SW	IGEA Pharma NV	-22.17%
IMMNOV.ST	Immunovia AB (publ)	-6927.82%
SCP.WA	Scope Fluidics SA	-901.53%
YGEN.L	Yourgene Health PLC	56.88%
ACARIX.ST	Acarix AB	90.21%
ALICR.PA	ICeram SA	53.76%
NN6.DE	NanoRepro AG	34.77%
SEQUA.BR	Sequana Medical NV	-3052.61%
BRA.WA	Braster SA	94.36%
CMXC	Cell MedX Corp	17.39%
CREO.L	Creo Medical Group PLC	47.50%
ELOS B.ST	Elos Medtech AB	34.94%
GPXMED.ST	Neola Medical AB	1448.32%
AWM.WA	Airway Medix SA	-50.00%
FLUI.ST	Fluicell AB	202.26%
IST.WA	Grupa Modne Zakupy SA	-824.21%
QLINEA.ST	Q linea AB	-470.49%
CEVI.ST	CellaVision AB	67.35%
CRAD B.ST	C Rad AB	47.00%
HANDI.ST	Handicare Group AB	56.00%
INM.WA	Inventionmed SA	35.13%
PHLOG B.ST	Pharmacolog I Uppsala AB (publ)	65.71%
SUS.ST	Surgical Science Sweden AB	67.63%
SECT B.ST	Sectra AB	50.03%
ALCAR.PA	Carmat SA	-338.50%
DEMG.L	Deltex Medical Group PLC	63.34%
EKTA B.ST	Elekta AB (publ)	37.80%
GETI B.ST	Getinge AB	47.33%
NANEXA.ST	Nanexa AB	107.08%
NSCI.L	Netscientific PLC	84.84%
PLUN.ST	ProstaLund AB	64.63%
ARJO B.ST	Arjo AB (publ)	43.45%